RAC1 and cardiac hypertrophy: These include the Rac1-mediated inhibition of NADH oxidase activity and downregulation of angiotensin AT1 receptor expression and inhibition of cardiac hypertrophy through an antioxidant mechanism involving the inhibition of Rac1 geranylgeranylation [26,27].